Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
26
2020
Comments on Draft Risk Evaluation for Trichloroethylene Due April 27 Bergeson & Campbell, P.C.
Feb
26
2020
New Jersey Labor Department Issues Companies Stop-Work Orders for Wage Violations Jackson Lewis P.C.
Feb
26
2020
California Federal Judge Certifies Class in “Pure” Honey Labeling Suit Keller and Heckman LLP
Feb
25
2020
Necessity Is The Mother Of Single Reference Anticipation By Inherency Foley & Lardner LLP
Feb
25
2020
CMS Proposes Significant Changes to Medicare Advantage & Part D for 2021 and Beyond, Part 2: CMS Proposes to Codify Supplemental Benefit Rules and Update MLR Mintz
Feb
25
2020
JUUL’s Efforts to Recruit Influencers Stark & Stark
Feb
24
2020
ECHA Urges Companies to Provide More Data on Nanoforms Bergeson & Campbell, P.C.
Feb
24
2020
Anticompetitive Patent-Listing Decision May Clear Patent Thicket for Generic Pharma Industry ArentFox Schiff LLP
Feb
24
2020
Is “Cannabis User” the Next Protected Class in California? Jackson Lewis P.C.
Feb
24
2020
340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges Mintz
Feb
24
2020
2019 FDA Precision Medicine Approvals: Progress At FDA Foley & Lardner LLP
Feb
24
2020
Federal Judge Dismisses Amended Complaint Over Dog Food Labeled as “Natural” Containing Trace Levels of Glyphosate Weed Killer Keller and Heckman LLP
Feb
21
2020
EPA Releases Proposed Supplemental SNUR on LCPFAC Chemical Substances Bergeson & Campbell, P.C.
Feb
21
2020
FDA Reopens Comment Period on General Principles for Food Standards Modernization Keller and Heckman LLP
Feb
21
2020
BRAG Biobased Products Blog: February 21, 2020 Bergeson & Campbell, P.C.
Feb
21
2020
California Update: New QR Code Certificate Requirements, Uptick in Enforcement Actions, and the Future of California’s Cannabis Regulators Sheppard, Mullin, Richter & Hampton LLP
Feb
21
2020
EPA Publishes Final List of Low-Priority Chemicals for Risk Evaluation under TSCA Bergeson & Campbell, P.C.
Feb
20
2020
Alcoholic Cider and Fermented Fruit Beverages – The Conflict Between Federal and Pennsylvania Law Norris McLaughlin P.A.
Feb
20
2020
JUUL Faces New Lawsuit Over Marketing Tactics Stark & Stark
Feb
19
2020
U.S. DOT Issues Warning Regarding Use Of CBD Products By DOT-Regulated Employees Jackson Lewis P.C.
Feb
19
2020
FDA Releases Third and Final Installment of Intentional Adulteration Draft Guidance Keller and Heckman LLP
Feb
18
2020
Eleventh Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
18
2020
Top Trends to Look For in Healthcare in 2020 Jackson Lewis P.C.
Feb
18
2020
Closing the Orphan Drug Act Loophole Mintz
Feb
17
2020
Ninth Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
17
2020
Humira: How far can drug makers go to protect their branded market? Wiggin and Dana LLP
Feb
15
2020
Opioid Update: Sixth Circuit Stays National Dispensing Discovery—For Now Squire Patton Boggs (US) LLP
Feb
14
2020
Corteva Announces It Will Cease Production of Embattled Insecticide Chlorpyrifos Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins